Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies

NCT00526838 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
84
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor decision

Conditions

Interventions

Sponsor

Exelixis